Johnson & Johnson Says Reaches Agreement With U.S. Agreement That Provides Johnson & Johnson Pharmaceutical Products An Exemption From U.S. Tariffs

Jan 8 (Reuters) - Johnson & Johnson JNJ.N:

• JOHNSON & JOHNSON REACHES AGREEMENT WITH U.S. GOVERNMENT TO IMPROVE ACCESS TO MEDICINES AND LOWER COSTS FOR MILLIONS OF AMERICANS; DELIVERS ON U.S. MANUFACTURING AND INNOVATION INVESTMENTS

• J&J - AGREEMENT PROVIDES JOHNSON & JOHNSON PHARMACEUTICAL PRODUCTS AN EXEMPTION FROM U.S. TARIFFS

• J&J - AGREEMENT WILL ALLOW MILLIONS OF AMERICANS TO PURCHASE MEDICINES AT SIGNIFICANTLY DISCOUNTED RATES

• J&J- ANNOUNCES TWO NEW ADDITIONAL MANUFACTURING FACILITIES TO BE BUILT IN NORTH CAROLINA AND PENNSYLVANIA; CONTINUES TO DELIVER ON $55 BILLION U.S. INVESTMENT

• J&J - JOINT AGREEMENT MEETS REQUESTS LAID OUT BY PRESIDENT TRUMP TO INDUSTRY AND PROVIDES COMPANY'S PHARMACEUTICAL PRODUCTS AN EXEMPTION FROM TARIFFS

• J&J: COMPANY IS PARTICIPATING IN TRUMPRX.GOV

• J&J - PROJECT TO CREATE 5,000 JOBS IN WILSON NORTH CAROLINA FACILITY

• J&J: EXPECTS TO ANNOUNCE ADDITIONAL U.S. INVESTMENTS LATER THIS YEAR